Mechanisms by which diabetes increases cardiovascular disease.
about
Lymphocytes in atherosclerosis.Effect on oxidative stress, glucose uptake level and lipid droplet content by Apigenin 7, 4'-dimethyl ether isolated from Piper longum LImplication of crystal water molecules in inhibitor binding at ALR2 active siteExercise training during diabetes attenuates cardiac ryanodine receptor dysregulation.Immune and inflammatory mechanisms of atherosclerosis (*)Exercise and Beta-Glucan Consumption (Saccharomyces cerevisiae) Improve the Metabolic Profile and Reduce the Atherogenic Index in Type 2 Diabetic Rats (HFD/STZ).Histopathological assessment of calcification and inflammation of calcific aortic valves from patients with and without diabetes mellitus.Differential regulation of aldose reductase expression during macrophage polarization depends on hyperglycemia.The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis.Exercise training prevents the development of cardiac dysfunction in the low-dose streptozotocin diabetic rats fed a high-fat diet.Association of Endocan, Ischemia-Modified Albumin, and hsCRP Levels With Endothelial Dysfunction in Type 2 Diabetes Mellitus.Phenolics from Garcinia mangostana Inhibit Advanced Glycation Endproducts Formation: Effect on Amadori Products, Cross-Linked Structures and Protein Thiols.Effects of glargine insulin on glycemic control in patients with diabetes mellitus type II undergoing off-pump coronary artery bypass graft.The Role of Advanced Glycation End Products in Diabetic Vascular Complications.The Role of Allograft Inflammatory Factor-1 in the Effects of Experimental Diabetes on B Cell Functions in the HeartHIF-1, Metabolism, and Diabetes in the Embryonic and Adult Heart
P2860
Q35082438-F2348A2E-9BA1-4D41-8218-B1D54E3A3710Q35650715-2524C80C-AF47-4EF8-8A57-4ED6527149CFQ35974866-91D27A8E-41E4-4D08-8958-89B61457436FQ37233149-0F41B6CC-A2A8-4CBF-A6F3-E39858B80A35Q37325024-B1A9F059-AC69-4DF7-A701-1B5CFAC006D0Q37535439-3FE170F2-F2B1-4731-801A-9046DD7263EDQ39648048-0DC1C588-D723-4AAC-87B8-D888A87E06C7Q39999962-5CED360A-F220-473B-9F75-DC9DDFF73BE8Q42284707-066643C7-CA94-4F87-9DF6-7B096CB58C53Q44087330-1FFED6BB-AF2A-44EB-BA5E-2EDE56626F2BQ47367683-F18FEFD7-4386-417B-8F3C-37DE66A5D7A6Q53771352-E0405C5B-3F9F-4DEA-8A61-FB837B9FB25EQ55006964-16A757EF-4857-42C4-BF1D-D522F03A9E1EQ55416114-2C75FFB5-A4AC-4FFD-B908-C3ECA948F286Q58749956-FB6E4404-8E22-44E2-9917-A6619EE477ABQ58777512-9599B7E5-04C0-4D7A-85BE-2380427205BD
P2860
Mechanisms by which diabetes increases cardiovascular disease.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Mechanisms by which diabetes increases cardiovascular disease.
@ast
Mechanisms by which diabetes increases cardiovascular disease.
@en
type
label
Mechanisms by which diabetes increases cardiovascular disease.
@ast
Mechanisms by which diabetes increases cardiovascular disease.
@en
prefLabel
Mechanisms by which diabetes increases cardiovascular disease.
@ast
Mechanisms by which diabetes increases cardiovascular disease.
@en
P2093
P2860
P1476
Mechanisms by which diabetes increases cardiovascular disease.
@en
P2093
Christian A Gleissner
Elena Galkina
Jerry L Nadler
P2860
P304
P356
10.1016/J.DDMEC.2007.12.005
P577
2007-01-01T00:00:00Z